A phase III study of sarilumab in polymyalgia rheumatica.
Phase of Trial: Phase III
Latest Information Update: 19 Dec 2017
At a glance
- Drugs Sarilumab (Primary)
- Indications Polymyalgia rheumatica
- Focus Therapeutic Use
- 19 Dec 2017 New trial record
- 13 Dec 2017 According to a Regeneron pharmaceutical media release, this study is planned to initiate in 2018.